| Novo Nordisk Pharma AG - Actrapid HM, Injektionslösung |
| 44610 | | 02 | | Actrapid HM | | Injektionslösung | | A10AB01 | | Insulin (Human) | | 22.08.1986 | | |
|
| Composition |
| insulinum humanum ADNr solutum 3.5 mg corresp. insulinum humanum ADNr solutum 100 U.I., glycerolum, zinci chloridum, natrii hydroxidum, acidum hydrochloridum, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium max. 1.02 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Insulinum Humanum adnr Solutum | 3.5 mg/ml correspond Insulinum Humanum adnr Solutum 100 UI/ml |
| | BAG: Active Agent | Dose |
|---|
| Insulinum Humanum adnr Solutum | 100 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Glycerol | | Metacresol | | Sodium Hydroxide | | Zinc Chlorideate |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 ml | | | B | | Yes | | 035 | Durchstechflasche(n) à 10 ml | 11.30 | 28.70 | B | SL | No |
|
